PMID- 17555971
OWN - NLM
STAT- MEDLINE
DCOM- 20071004
LR  - 20101118
IS  - 1010-7940 (Print)
IS  - 1010-7940 (Linking)
VI  - 32
IP  - 2
DP  - 2007 Aug
TI  - What to expect after tricuspid valve replacement? Long-term results.
PG  - 296-300
AB  - OBJECTIVE: Current knowledge in long-term results of tricuspid valve replacement 
      is limited. Present study reviews our experience from a consecutive series. 
      METHODS: Forty-two patients (16 male, 26 female; mean age: 33+/-15) underwent 
      tricuspid valve replacement between March 1987 and December 2004. The etiology 
      was rheumatic in 64%, Ebstein's anomaly in 31%, and endocarditis in 5%. Nineteen 
      patients were in New York Heart Association (NYHA) Class III functional capacity 
      (45%), and 13 in class IV (31%). Twenty patients (48%) underwent isolated 
      tricuspid valve replacement. The remaining underwent combined (mitral and/or 
      aortic) valve replacements. Tricuspid replacement device was mechanical in 31% 
      and bioimplant in 69%. RESULTS: Hospital mortality was 26%. Rheumatic etiology, 
      reoperation and elevated pulmonary artery pressure were associated with higher 
      early mortality. The patients with decreased functional capacity (NYHA Class 
      III/IV), congestive symptoms and rheumatic origin were more prone to low cardiac 
      output development. The Kaplan-Meier survivals were 37% at 10 years and 30% at 15 
      years. The 10-year event-free survival was 31%. Elevated pulmonary artery 
      pressure and rheumatic etiology unfavorably affected the long-term results. The 
      average functional capacity in survivors improved significantly after operation. 
      CONCLUSIONS: Any tricuspid disease not amenable to repair thus necessitating 
      replacement is an unfortunate situation since both the short and long-term 
      results of valve replacement are suboptimal in regard to those of left-sided 
      valve replacements, probably due to different structural and geometrical 
      characteristics of right ventricle and the low-pressure venous system 
      hemodynamics. Etiology, clinical presentation and pulmonary vascular hemodynamics 
      are major determinants of the outcome.
FAU - Iscan, Zafer H
AU  - Iscan ZH
AD  - Department of Cardiovascular Surgery, Yuksek Ihtisas Hospital of Turkey, Ankara, 
      Turkey.
FAU - Vural, Kerem M
AU  - Vural KM
FAU - Bahar, Ilknur
AU  - Bahar I
FAU - Mavioglu, Levent
AU  - Mavioglu L
FAU - Saritas, Ahmet
AU  - Saritas A
LA  - eng
PT  - Journal Article
DEP - 20070606
PL  - Germany
TA  - Eur J Cardiothorac Surg
JT  - European journal of cardio-thoracic surgery : official journal of the European 
      Association for Cardio-thoracic Surgery
JID - 8804069
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Bioprosthesis
MH  - Blood Pressure/physiology
MH  - Cardiac Output, Low/complications/physiopathology
MH  - Child
MH  - Ebstein Anomaly/complications/physiopathology
MH  - Female
MH  - Heart Failure/complications/physiopathology
MH  - Heart Valve Diseases/etiology/physiopathology/*surgery
MH  - Heart Valve Prosthesis Implantation/*methods/mortality
MH  - Humans
MH  - Kaplan-Meier Estimate
MH  - Male
MH  - Middle Aged
MH  - Postoperative Complications
MH  - Pulmonary Artery/physiopathology
MH  - Reoperation
MH  - Rheumatic Diseases/complications/physiopathology
MH  - Risk Factors
MH  - Time Factors
MH  - Treatment Outcome
MH  - Tricuspid Valve/*surgery
EDAT- 2007/06/09 09:00
MHDA- 2007/10/05 09:00
CRDT- 2007/06/09 09:00
PHST- 2007/03/14 00:00 [received]
PHST- 2007/04/13 00:00 [revised]
PHST- 2007/05/07 00:00 [accepted]
PHST- 2007/06/09 09:00 [pubmed]
PHST- 2007/10/05 09:00 [medline]
PHST- 2007/06/09 09:00 [entrez]
AID - S1010-7940(07)00437-X [pii]
AID - 10.1016/j.ejcts.2007.05.003 [doi]
PST - ppublish
SO  - Eur J Cardiothorac Surg. 2007 Aug;32(2):296-300. doi: 
      10.1016/j.ejcts.2007.05.003. Epub 2007 Jun 6.